Arch Therapeutics Inc
OTC:ARTH

Watchlist Manager

Arch Therapeutics Inc

OTC:ARTH

Watchlist

Dividends

Price: 0.0001 USD Market Closed

Market Cap: 444 USD

Have any thoughts about
Arch Therapeutics Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 0.0001 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

ARTH Alert

Arch Therapeutics Inc

0.0001

0.0000 (0%)

52 Week Range	0.0001 1.05
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Arch Therapeutics Inc

What unique competitive advantages
does Arch Therapeutics Inc hold over its rivals?

What risks and challenges
does Arch Therapeutics Inc face in the near future?

Provide an overview of the primary business activities
of Arch Therapeutics Inc.

Show me price targets
for Arch Therapeutics Inc made by professional analysts.

Provide an overview of the primary business activities
of Arch Therapeutics Inc.

What unique competitive advantages
does Arch Therapeutics Inc hold over its rivals?

What risks and challenges
does Arch Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Arch Therapeutics Inc recently?

Show all valuation multiples
for Arch Therapeutics Inc.

Provide P/S
for Arch Therapeutics Inc.

Provide P/E
for Arch Therapeutics Inc.

Provide P/OCF
for Arch Therapeutics Inc.

Provide P/FCFE
for Arch Therapeutics Inc.

Provide P/B
for Arch Therapeutics Inc.

Provide EV/S
for Arch Therapeutics Inc.

Provide EV/GP
for Arch Therapeutics Inc.

Provide EV/EBITDA
for Arch Therapeutics Inc.

Provide EV/EBIT
for Arch Therapeutics Inc.

Provide EV/OCF
for Arch Therapeutics Inc.

Provide EV/FCFF
for Arch Therapeutics Inc.

Provide EV/IC
for Arch Therapeutics Inc.

Show me price targets
for Arch Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Arch Therapeutics Inc?

How accurate were the past Revenue estimates
for Arch Therapeutics Inc?

What are the Net Income projections
for Arch Therapeutics Inc?

How accurate were the past Net Income estimates
for Arch Therapeutics Inc?

What are the EPS projections
for Arch Therapeutics Inc?

How accurate were the past EPS estimates
for Arch Therapeutics Inc?

What are the EBIT projections
for Arch Therapeutics Inc?

How accurate were the past EBIT estimates
for Arch Therapeutics Inc?

Compare the revenue forecasts
for Arch Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Arch Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Arch Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Arch Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Arch Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Arch Therapeutics Inc with its peers.

Analyze the financial leverage
of Arch Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Arch Therapeutics Inc.

Provide ROE
for Arch Therapeutics Inc.

Provide ROA
for Arch Therapeutics Inc.

Provide ROIC
for Arch Therapeutics Inc.

Provide ROCE
for Arch Therapeutics Inc.

Provide Gross Margin
for Arch Therapeutics Inc.

Provide Operating Margin
for Arch Therapeutics Inc.

Provide Net Margin
for Arch Therapeutics Inc.

Provide FCF Margin
for Arch Therapeutics Inc.

Show all solvency ratios
for Arch Therapeutics Inc.

Provide D/E Ratio
for Arch Therapeutics Inc.

Provide D/A Ratio
for Arch Therapeutics Inc.

Provide Interest Coverage Ratio
for Arch Therapeutics Inc.

Provide Altman Z-Score Ratio
for Arch Therapeutics Inc.

Provide Quick Ratio
for Arch Therapeutics Inc.

Provide Current Ratio
for Arch Therapeutics Inc.

Provide Cash Ratio
for Arch Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Arch Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Arch Therapeutics Inc?

What is the current Free Cash Flow
of Arch Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Arch Therapeutics Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

ARTH Price Targets Summary
Arch Therapeutics Inc

There are no price targets for ARTH.

ARTH Lowest Forecast

Wall Street Target

Not Available

ARTH Average Forecast

Wall Street Target

Not Available

ARTH Highest Forecast

Wall Street Target

Not Available

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

Arch Therapeutics Inc Competitors:
Price Targets

7979

Shofu Inc

48% Upside

300981

Zhonghong Pulin Medical Products Co Ltd

1% Downside

VIMIAN

Vimian Group AB

17% Upside

1501

Shanghai Kindly Medical Instruments Co Ltd

42% Upside

7979

Shofu Inc

48% Upside

300981

Zhonghong Pulin Medical Products Co Ltd

1% Downside

VIMIAN

Vimian Group AB

17% Upside

1501

Shanghai Kindly Medical Instruments Co Ltd

42% Upside

7741

Hoya Corp

35% Upside

GENT

Gentian Diagnostics ASA

8% Upside

SMTI

Sanara Medtech Inc

69% Upside

PNV

Polynovo Ltd

80% Upside

Revenue
Forecast

Revenue Estimate
Arch Therapeutics Inc

The compound annual growth rate of Arch Therapeutics Inc's revenue for the next 3 years is 1 543%.

N/A

Past Growth

1 543%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Arch Therapeutics Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-6%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Arch Therapeutics Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-82%

Average Miss

What are analyst estimates?

What is ARTH's stock price target?

Not Available

ARTH doesn't have any price targets made by Wall Street professionals.

What is Arch Therapeutics Inc's Revenue forecast?

Projected CAGR
1 543%

The compound annual growth rate of Arch Therapeutics Inc's revenue for the next 3 years is 1 543%.

	Arch Therapeutics Inc OTC:ARTH	0.0001 USD
R	Rhinebeck Bancorp Inc NASDAQ:RBKB	11.98 USD 0.59%
	Godrej Industries Ltd NSE:GODREJIND	1 165.3 INR 0.54%

	Franklin Covey Co NYSE:FC	22.1 USD -8.56%
	Mohawk Industries Inc NYSE:MHK	110.84 USD -0.4%
	Ardmore Shipping Corp NYSE:ASC	10.25 USD 0.49%
	ASGN Inc NYSE:ASGN	52.84 USD 1.23%
	Skyworks Solutions Inc NASDAQ:SWKS	78.76 USD 0.74%
	Weatherford International PLC NASDAQ:WFRD	54.15 USD -2.11%

	Johnson & Johnson NYSE:JNJ	156.01 USD 0.29%
	Bank of America Corp NYSE:BAC	48.93 USD 0.45%
	Mastercard Inc NYSE:MA	569.24 USD 1.37%
	Salesforce Inc NYSE:CRM	272.15 USD 1.09%
	Abbvie Inc NYSE:ABBV	189.28 USD -0.77%
	Home Depot Inc NYSE:HD	371.68 USD -0.05%

	Arista Networks Inc NYSE:ANET	102.52 USD 1.37%
	Deckers Outdoor Corp NYSE:DECK	106.2 USD -0.06%
	Visa Inc NYSE:V	358.86 USD 1.31%
	Texas Pacific Land Corp NYSE:TPL	1 075.97 USD 0.38%
	KLA Corp NASDAQ:KLAC	924.58 USD 0.38%
	Manhattan Associates Inc NASDAQ:MANH	199.93 USD 0.61%

	Salesforce Inc NYSE:CRM	272.15 USD 1.09%
	Accenture PLC NYSE:ACN	304.78 USD 0.82%
	ServiceNow Inc NYSE:NOW	1 044.69 USD 3.46%
	Spotify Technology SA NYSE:SPOT	725.05 USD 2.19%
	EOG Resources Inc NYSE:EOG	123.15 USD 0.22%
	Applied Materials Inc NASDAQ:AMAT	191.05 USD 0.55%

Arch Therapeutics Inc
OTC:ARTH

Wall Street
Price Targets

ARTH Price Targets Summary
Arch Therapeutics Inc

Revenue
Forecast

Revenue Estimate
Arch Therapeutics Inc

Operating Income
Forecast

Operating Income Estimate
Arch Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Arch Therapeutics Inc

See Also

What is ARTH's stock price target?

Not Available

What is Arch Therapeutics Inc's Revenue forecast?

Projected CAGR
1 543%

Company

Help

Tools

Stocks

Arch Therapeutics Inc OTC:ARTH

Wall Street Price Targets

ARTH Price Targets Summary Arch Therapeutics Inc

Revenue Forecast

Revenue Estimate Arch Therapeutics Inc

Operating Income Forecast

Operating Income Estimate Arch Therapeutics Inc

Net Income Forecast

Net Income Estimate Arch Therapeutics Inc

See Also

What is ARTH's stock price target? Not Available

What is Arch Therapeutics Inc's Revenue forecast? Projected CAGR 1 543%

Company

Help

Tools

Stocks

Arch Therapeutics Inc
OTC:ARTH

Wall Street
Price Targets

ARTH Price Targets Summary
Arch Therapeutics Inc

Revenue
Forecast

Revenue Estimate
Arch Therapeutics Inc

Operating Income
Forecast

Operating Income Estimate
Arch Therapeutics Inc

Net Income
Forecast

Net Income Estimate
Arch Therapeutics Inc

What is ARTH's stock price target?

Not Available

What is Arch Therapeutics Inc's Revenue forecast?

Projected CAGR
1 543%